Volume 30, Issue 7 (10-2022)
JSSU 2022, 30(7): 5032-5041 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Gharibi S, Aghaei S, Shahvazian E, Mahmoodi M B, Sahami-Fard M H, kolahdouz P et al . Association of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients. JSSU 2022; 30 (7) :5032-5041
URL: http://jssu.ssu.ac.ir/article-1-5593-en.html
URL: http://jssu.ssu.ac.ir/article-1-5593-en.html
Saba Gharibi 
, Shiva Aghaei , Ensieh Shahvazian , Mohammad Bagher Mahmoodi , Mohammad Hossein Sahami-Fard , Parisa Kolahdouz , Ehsan Farashahi Yazd *
, Shiva Aghaei , Ensieh Shahvazian , Mohammad Bagher Mahmoodi , Mohammad Hossein Sahami-Fard , Parisa Kolahdouz , Ehsan Farashahi Yazd *
Abstract: (583 Views)
Introduction: Patients with diabetes are prone to develop complications related to the retina. So far, several genes have been reported in connection with the progression of retinopathy, and a group of these genes is genes involved in angiogenesis. CXCL12 and CXCR4 genes are among the most important genes in this path, which have been less studied and investigated. The aim of this study was to determine the relationship between polymorphism of CXCL12 (rs1801157) and CXCR4 (rs2228014) genes and the risk of proliferative diabetic retinopathy in the population of Yazd City.
Methods: In the present case-control study, rs2228014 and rs1801157 polymorphisms were investigated among 103 patients with diabetes in two groups, case and control. In this study, the control group included 49 diabetic patients who did not show retinopathy complications, and the case group consisted of 54 diabetic patients with proliferative retinopathy complications. The Genotyping of rs2228014 polymorphism was examined by ARMS-PCR method and rs1801157 variant by RFLP-PCR technique. The statistical analysis of data was conducted using SPSS software version 16 and chi-square test.
Results: Our results represented no association among the rs1801157 and rs2228014 polymorphisms and the risk of proliferative diabetic retinopathy (P>0.05).
Conclusion: This study did not confirm association of the rs1801157 and rs2228014 polymorphisms with proliferative diabetic retinopathy and further studies are required to investigate the correlation of polymorphisms of interest with PDR.
Methods: In the present case-control study, rs2228014 and rs1801157 polymorphisms were investigated among 103 patients with diabetes in two groups, case and control. In this study, the control group included 49 diabetic patients who did not show retinopathy complications, and the case group consisted of 54 diabetic patients with proliferative retinopathy complications. The Genotyping of rs2228014 polymorphism was examined by ARMS-PCR method and rs1801157 variant by RFLP-PCR technique. The statistical analysis of data was conducted using SPSS software version 16 and chi-square test.
Results: Our results represented no association among the rs1801157 and rs2228014 polymorphisms and the risk of proliferative diabetic retinopathy (P>0.05).
Conclusion: This study did not confirm association of the rs1801157 and rs2228014 polymorphisms with proliferative diabetic retinopathy and further studies are required to investigate the correlation of polymorphisms of interest with PDR.
Type of Study: Original article |
Subject:
Genetics
Received: 2021/10/30 | Accepted: 2022/01/23 | Published: 2022/10/7
Received: 2021/10/30 | Accepted: 2022/01/23 | Published: 2022/10/7
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
